Jinying Lu
Jiangsu Key Lab Of Cancer Biomarkers
Nanjing, China
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Reinvigorating COTL1high NK cells via GITR signalling overcomes immune checkpoint blockade resistance in tsMHC-I-impaired tumours.
Journal: Nature cell biology
Published: May 17, 2025
Tertiary Lymphoid Structure-Associated B Cells Enhance CXCL13+CD103+CD8+ Tissue-Resident Memory T-Cell Response to Programmed Cell Death Protein 1 Blockade in Cancer Immunotherapy.
Journal: Gastroenterology
Published: May 26, 2023
Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations.
Journal: Journal of visualized experiments : JoVE
Published: March 13, 2023
Clinicopathological and predictive value of MAIT cells in non-small cell lung cancer for immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: January 02, 2023
Gut microbiota-derived short-chain fatty acids regulate group 3 innate lymphoid cells in HCC.
Journal: Hepatology (Baltimore, Md.)
Published: February 01, 2022
Hepatic stellate cell activation and senescence induced by intrahepatic microbiota disturbances drive progression of liver cirrhosis toward hepatocellular carcinoma.
Journal: Journal for immunotherapy of cancer
Published: December 04, 2021
Single-cell profiling of human CD127+ innate lymphoid cells reveals diverse immune phenotypes in hepatocellular carcinoma.
Journal: Hepatology (Baltimore, Md.)
Published: September 06, 2021
Tumor-associated macrophages promote PD-L1 expression in tumor cells by regulating PKM2 nuclear translocation in pancreatic ductal adenocarcinoma.
Journal: Oncogene
Published: June 09, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026